← FDA DRUG APPROVALS

FDA ANDA · ANDA209468

DEXMETHYLPHENIDATE HYDROCHLORIDE

Sponsor: LANNETT CO INC

APPLICATION
ANDA209468
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-25
LATEST ACTION
2023-07-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DEXMETHYLPHENIDATE HYDROCHLORIDEDiscontinued
DEXMETHYLPHENIDATE HYDROCHLORIDE 10MG · TABLET · ORAL
DEXMETHYLPHENIDATE HYDROCHLORIDEDiscontinued
DEXMETHYLPHENIDATE HYDROCHLORIDE 2.5MG · TABLET · ORAL
DEXMETHYLPHENIDATE HYDROCHLORIDEDiscontinued
DEXMETHYLPHENIDATE HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

2023-07-21Labeling · Supplement 4 · standardAP
2021-06-25Labeling · Supplement 3 · standardAP
2019-11-29Labeling · Supplement 2 · standardAP
2017-09-25UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →